Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
Filed May 13, 2025 · 10-Q · 43 days after period end · 0001091818-25-000053
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$935.46K | -$130.81K | -$130.01K | -$132.41K |
| EPS Diluted | -$0.03 | $0.00 | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 13, 2025 · 43 d after period end